BioGaia AB (publ) (LON:0GTN)
London
· Delayed Price · Currency is GBP · Price in SEK 128.15
-0.04 (-0.03%)
At close: Feb 21, 2025
BioGaia AB Income Statement
Financials in millions SEK. Fiscal year is January - December.
Millions SEK. Fiscal year is Jan - Dec.
Fiscal Year | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2019 - 2015 |
|---|---|---|---|---|---|---|
Period Ending | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2019 - 2015 |
| Revenue | 1,423 | 1,297 | 1,104 | 785.11 | 747.08 | Upgrade
|
| Revenue Growth (YoY) | 9.73% | 17.44% | 40.61% | 5.09% | -2.77% | Upgrade
|
| Cost of Revenue | 391.98 | 346.32 | 302.03 | 202.16 | 200.16 | Upgrade
|
| Gross Profit | 1,031 | 950.19 | 801.93 | 582.95 | 546.92 | Upgrade
|
| Selling, General & Admin | 464.28 | 402.51 | 360.62 | 230.76 | 197.76 | Upgrade
|
| Research & Development | 157.1 | 106.78 | 106.81 | 105.47 | 104.66 | Upgrade
|
| Other Operating Expenses | - | - | - | 0 | - | Upgrade
|
| Operating Expenses | 621.38 | 509.28 | 467.42 | 336.23 | 302.43 | Upgrade
|
| Operating Income | 409.36 | 440.91 | 334.51 | 246.72 | 244.49 | Upgrade
|
| Interest Expense | -14.92 | -15.8 | -5.39 | -1.13 | -0.72 | Upgrade
|
| Interest & Investment Income | 39.37 | 41.53 | 7.96 | 0.11 | 0.16 | Upgrade
|
| Currency Exchange Gain (Loss) | 14.01 | 1.82 | 26.79 | 11.14 | -17.43 | Upgrade
|
| Other Non Operating Income (Expenses) | - | - | 3.56 | - | - | Upgrade
|
| EBT Excluding Unusual Items | 447.82 | 468.46 | 367.44 | 256.84 | 226.5 | Upgrade
|
| Merger & Restructuring Charges | - | - | - | -4.23 | - | Upgrade
|
| Other Unusual Items | - | 0.38 | 80.17 | 0.1 | 1.08 | Upgrade
|
| Pretax Income | 447.82 | 468.83 | 447.61 | 252.71 | 227.58 | Upgrade
|
| Income Tax Expense | 96.43 | 103.48 | 73.84 | 56.44 | 47.85 | Upgrade
|
| Earnings From Continuing Operations | 351.39 | 365.35 | 373.77 | 196.27 | 179.73 | Upgrade
|
| Net Income to Company | 351.39 | 365.35 | 373.77 | 196.27 | 179.73 | Upgrade
|
| Net Income | 351.39 | 365.35 | 373.77 | 196.27 | 179.73 | Upgrade
|
| Net Income to Common | 351.39 | 365.35 | 373.77 | 196.27 | 179.73 | Upgrade
|
| Net Income Growth | -3.82% | -2.25% | 90.44% | 9.20% | -4.07% | Upgrade
|
| Shares Outstanding (Basic) | 101 | 101 | 101 | 101 | 89 | Upgrade
|
| Shares Outstanding (Diluted) | 101 | 101 | 101 | 101 | 89 | Upgrade
|
| Shares Change (YoY) | 0.09% | - | - | 13.11% | 2.18% | Upgrade
|
| EPS (Basic) | 3.48 | 3.62 | 3.70 | 1.94 | 2.01 | Upgrade
|
| EPS (Diluted) | 3.48 | 3.62 | 3.70 | 1.94 | 2.01 | Upgrade
|
| EPS Growth | -3.91% | -2.22% | 90.72% | -3.64% | -6.10% | Upgrade
|
| Free Cash Flow | 359.46 | 377.4 | 301.03 | 215.5 | 205.18 | Upgrade
|
| Free Cash Flow Per Share | 3.56 | 3.74 | 2.98 | 2.13 | 2.30 | Upgrade
|
| Dividend Per Share | 1.950 | 1.900 | 1.450 | 0.730 | 0.682 | Upgrade
|
| Dividend Growth | 2.63% | 31.03% | 98.63% | 7.04% | -9.07% | Upgrade
|
| Gross Margin | 72.45% | 73.29% | 72.64% | 74.25% | 73.21% | Upgrade
|
| Operating Margin | 28.77% | 34.01% | 30.30% | 31.43% | 32.73% | Upgrade
|
| Profit Margin | 24.70% | 28.18% | 33.86% | 25.00% | 24.06% | Upgrade
|
| Free Cash Flow Margin | 25.27% | 29.11% | 27.27% | 27.45% | 27.46% | Upgrade
|
| EBITDA | 486.06 | 455.44 | 348.71 | 259.98 | 255.16 | Upgrade
|
| EBITDA Margin | 34.16% | 35.13% | 31.59% | 33.11% | 34.15% | Upgrade
|
| D&A For EBITDA | 76.7 | 14.53 | 14.2 | 13.25 | 10.66 | Upgrade
|
| EBIT | 409.36 | 440.91 | 334.51 | 246.72 | 244.49 | Upgrade
|
| EBIT Margin | 28.77% | 34.01% | 30.30% | 31.43% | 32.73% | Upgrade
|
| Effective Tax Rate | 21.53% | 22.07% | 16.50% | 22.33% | 21.03% | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.